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AN UPDATE ON THEIR INTERACTING PARTNERS
Alain Chariot,* Jacques Gielen, Marie-Paule Merville and Vincent Bours
LABORATORY OF MEDICAL CHEMISTRY AND MEDICAL ONCOLOGY, UNIVERSITY OF LIEGE, LIEGE, BELGIUM
ABSTRACT. Homeodomain-containing proteins are transcription regulators controlling the coordinated
expression of genes involved in development, differentiation, and cellular transformation. They share a highly
conserved 60-amino-acid region (the “homeodomain”), which allows them to bind DNA and modulate the
expression of multiple target genes, whose identities remain largely unknown. Although each HOX gene product
exhibits in vivo specificity, they harbor very similar DNA-binding affinities in vitro, suggesting that other
mechanisms such as protein–protein interactions are critical to modulate their function. In this commentary, we
describe the proteins that can interact with the HOX gene products, including newly identified partners such as
CREB binding protein and the NF-kB/IkB-a proteins. We also outline the molecular programs that are regulated
by the transcriptional complexes involving the HOX gene products and where new pharmacological tools could
find interesting targets. BIOCHEM PHARMACOL 58;12:1851–1857, 1999. © 1999 Elsevier Science Inc.
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Molecular characterization of the genes whose sequence
alterations cause dramatic phenotypes in the fruit fly,
Drosophila melanogaster, has led to the identification of the
HOX† genes, defined as “master genes” for the crucial role
they play in embryogenesis [1]. They all share a homeobox
region, known as a 180-bp highly conserved sequence [2–4]
encoding a 60-amino-acid DNA-binding domain (the “ho-
meodomain”) [5], conferring to the resulting proteins the
ability to act as transcription factors [6]. The 39 human
HOX genes are organized in four distinct clusters (loci A, B,
C, and D) and can be aligned on the basis of homology
within the homeobox to define paralogs [7–10]. Their
chromosomal localization within the clusters is closely
related to their spatio-temporal pattern of expression along
the antero-posterior axis of the developing embryo (“colin-
earity”) [11]. Beside a critical involvement in cell fate
determination, the HOX genes also play a key role in
differentiation and tumoral development [12, 13].
Extensive expression studies have demonstrated that Hox
genes harbor overlapping domains of expression in the
developing embryos. This observation thus implied that
more than one HOX protein is expressed in a given cell
(“HOX code”) [14], and they probably compete for com-
mon binding sites within the regulatory sequences of their
target genes. Although each HOX protein exhibits in vivo
specificity, as demonstrated by both targeted gene knockout
and gain of function experiments [10, 15], they all share
very similar DNA-binding affinities in vitro [16, 17]. This
paradoxical observation then raised the following ques-
tions: how can multiple homeodomain-containing proteins
exert their in vivo specificity, and what are the rules that
govern their ability to activate or repress target genes? In
this commentary, we tentatively describe the molecular
mechanisms that may resolve these critical issues, and we
focus our attention on the mammalian HOX proteins.
IN VITRO AND IN VIVO SPECIFICITIES OF
THE HOX GENE PRODUCTS: ROLE OF
THE COFACTORS
DNA–protein interactions clearly contribute to the in vivo
specificity of each HOX protein [18, 19]. The identification
of the functional domains of HOX gene products appears to
depend on the target DNA sequence but also on the
physiological context in which the HOX proteins interact
with the DNA [20], thus suggesting that interactions with
other proteins, defined as “cofactors,” are required to
regulate their function.
In the search for Hox interacting partners, the first
candidates to be identified were the homeodomain-con-
taining PBC proteins, which include the Drosophila extra-
denticle and the vertebrate Pbx products [21]. Multiple
studies subsequently illustrated the critical role played by
the pentapeptide, a conserved domain located upstream
from the DNA-binding domain of most Antennapedia-like
HOX proteins, for the interaction with PBX [21–23].
Interestingly, this interaction contributed to the in vivo
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specificity of the HOX proteins [24] through generation of
selective HOX/PBX heterodimers bound on a specific
bipartite sequence, TGATNNAT [g/t] [g/a] [25–27]. How-
ever, it was likely that interactions with additional partners
were required, since PBX proteins did not confer DNA
binding selectivity on HOX proteins for their target genes
[28].
Because most of the AbdB-like HOX proteins do not
harbor the conserved pentapeptide, they cannot interact
with Pbx [29]. It then was expected that interactions with
other partners might regulate their function as well. Indeed,
heterodimeric complexes between AbdB-like Hox and
Meis1 proteins have been described [30]. In this case,
AbdB-like proteins clearly stabilized Meis–DNA interac-
tions. To our knowledge, it is unclear whether functional
HOX–Pbx–Meis trimers exist in vivo, although such a
complex involving HOXA9 has been identified recently in
vitro and in myeloid cells [31]. On the other hand, stable
Meis–Pbx dimers have been identified [32, 33]. Moreover,
Prep1, another protein highly related to Meis1, is also a
Pbx-interacting partner [34, 35] and is a member of the
TALE (“three amino acid loop extension”) family of
homeodomain-containing proteins along with Meis and
PBC [36]. Interestingly, nuclear localization of PBC pro-
teins might be regulated tightly by their interacting part-
ners, as demonstrated by both biochemical and genetic
studies in Drosophila [37]. Based on the existence of PBC-
containing complexes harboring Hox-independent func-
tions, an attractive hypothesis has been proposed recently
[26]. The authors suggest that HOX, instead of PBC
proteins, are the real cofactors and may be critical for the
regulation of PBC-containing complexes.
Histone and Transcription Factor Acetylations: Two
Ways to Modulate Hox Protein Functions?
A breakthrough has been made recently regarding the way
transcription factors access their target sites, despite a
“repressive” chromatin environment. Indeed, the identifi-
cation of proteins harboring intrinsic histone acetyltrans-
ferase activities allowed major insights into molecular
mechanisms of histone acetylation, a phenomenon corre-
lated with transcriptional activity in eukaryotic cells [38]. A
histone acetyltransferase (“HAT”) activity has been attrib-
uted to several proteins, including CBP/p300 coactivators
[39, 40]. Both CBP/p300 proteins were known previously to
enhance the transcription potential of a variety of proteins
by acting as a bridge or an “adaptor” between the DNA-
binding regulators and the basal transcription complex
[41–43]. It is now clear that this enhancement of the
transcription potential of DNA-binding proteins by CBP/
p300 products is mediated by acetylation of lysine residues
at the N-terminal tail of histones. This process presumably
destabilizes the nucleosome and facilitates the access of
transcription factors to DNA.
It was likely that CBP/p300 coactivators enhanced the
transcription potential of the homeodomain-containing
proteins as well. In this context, Pit-1 transcriptional
activity was increased significantly by CBP ( [44, 45];
Chariot et al., unpublished data). Moreover, we recently
demonstrated a physical interaction between HOXB7, a
transactivating protein [46 – 48], and the coactivator
CBP in vitro and in vivo [49]. This interaction led to an
enhanced transactivation by this HOX protein and
required the N-terminal of HOXB7 as well as two
domains located at the C-terminal part of CBP [49].
Multiple mechanisms that are not mutually exclusive
may account for this enhancement of HOXB7 transactiva-
tion potential by CBP (Fig. 1). The first mechanism implies
CBP as an adaptor or a bridge between HOXB7 bound to its
DNA sequence and the basal transcription apparatus, as
previously suggested for other transcription factors [41, 42].
The second mechanism refers to a modification of the
chromatin conformation within the HOX-binding site due
FIG. 1. Schematic illustration of the HOXB7/PBX heterodimer bound to a double-stranded DNA site. The coactivator/acetyltrans-
ferase complex composed of CBP/p300 and P/CAF products allowed the homeodomain-containing proteins to access their binding site
through acetylation of the histones, represented as four dark circles. Hypothetical acetylation of HOXB7 by CBP is shown. The basal
transcription complex, which includes TBP, TFIIA, TFIIB, TFIIE, TFIIF, TFIIH, TFIIJ, the TAFs, and RNA polymerase II, is
depicted.
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to the acetylation of the histones either by CBP or by
another histone acetyltransferase such as P/CAF, which is
also recruited by CBP [50]. The access of the HOXB7
protein to its target sites would then be facilitated. A third
mechanism is based on the demonstration that CBP can
interact with multiple transcription factors. Then, CBP
might bring HOXB7 interacting proteins together with
HOXB7, thus creating a strong transactivating complex. A
fourth mechanism would involve direct HOXB7 acetyla-
tion by CBP. Indeed, we raised the possibility that HOXB7
function may be regulated by its acetylation through its
N-terminal domain, since the deacetylase inhibitor TSA
increases HOXB7-dependent transcription but does not
enhance significantly the transactivation effect of two
HOXB7 products lacking this N-terminal region. Interest-
ingly, a lysine residue within this N-terminal domain
represents a potential target for acetylation. It then would
be of interest to investigate whether HOXB7 is acetylated
in vivo and whether such post-translational modification is
critical for the regulation of its functions. A similar phe-
nomenon has been demonstrated experimentally for a
growing number of transcription factors including TFIIE,
TFIIH [51], p53 [52], EKLF [53], GATA-1 [54], and dTCF
[55]. Therefore, it is believed that acetylation may affect
and regulate a variety of substrates involved in distinct
pathways.
We now may wonder how interactions of HOX proteins
with CBP and/or other coactivators regulate their function
in vivo. In our experimental system, the HOXB7 N-terminal
domain was crucial for the interaction with CBP in vitro
and in transfected cells. Since this region is less conserved
among the HOX proteins, it is tempting to speculate that
this interaction contributes to the in vivo specificity of the
HOX genes. Although not yet experimentally demon-
strated, it is likely that CBP also mediates the transcrip-
tional properties of other HOX gene products. It would be
of interest to identify the functional domains of the HOX
proteins involved in the process. In this context, a recent
report demonstrated a functional interaction between CBP
and the oncogenic NUP98-HOXA9 fusion protein medi-
ated by the nucleoporin-specific FG repeats [56]. However,
the HOXA9 portion of the fusion protein did not co-
immunoprecipitate with CBP, whereas the ability of the
wild-type HOXA9 protein to interact with this coactivator
remains unknown. In any case, the limiting levels of the
CBP/p300 proteins within the nucleus may be crucial in
selecting the HOX candidates with which to interact.
Indeed, competition between distinct families of transcrip-
tion factors for interaction with CBP can influence their
function dramatically [57]. Therefore, it will be interesting
to define the parameters that govern the ability of multiple
HOX proteins to interact preferentially with limiting levels
of CBP and/or other coactivators within a single cell and to
determine whether these parameters can be integrated to a
whole organism.
Modulation of Hox Protein Function by Phosphorylation
It has been known for many years that post-translational
modifications of transcription factors can modulate their
function materially. Among these processes, phosphoryla-
tion/dephosphorylation is the most widely described regu-
lating process [58]. Due to many putative phosphorylation
sites and to the elevated number of HOX genes, the
modulation of HOX protein functions by phosphorylation
still remains largely unexplored. However, few reports have
attempted to address this issue. The Drosophila Antennape-
dia protein was phosphorylated by casein kinase II at
critical residues [59]. An Antennapedia mutant where the
phosphorylated residue is replaced by alanine failed to
interact with extradenticle, thus causing severe defects in
both thoracic and abdominal development [59]. Interest-
ingly, this hypothesis can be extended to other homeodo-
main-containing proteins that are not encoded by the
clustered HOX genes (“divergent HOX proteins”). Indeed,
a physical interaction between HOX11 and phosphatases
PP2A and PP1 has been reported [60]. Moreover, this
process disrupts a G2/M cell-cycle checkpoint. These ob-
servations emphasize the crucial role played by phosphory-
lation/dephosphorylation events in the regulation of HOX
proteins. They also suggest that post-translational modifi-
cation of HOX proteins can affect the cell cycle and
modulate complex molecular programs involved in cell
proliferation and differentiation. These results also raise a
number of questions. Which HOX proteins are preferen-
tially phosphorylated? Are the putative HOX protein ki-
nases/phosphatases spatio-temporally regulated in the de-
veloping embryo and in differentiated organs? Future inves-
tigations undoubtedly will provide further insights
regarding these key issues.
Homeodomain-Containing Proteins and NF-kB
Members: Evidence for Cross-Talk?
To study further the transcriptional effects of HOX pro-
teins, we recently demonstrated that HOXB7 interacts with
ubiquitously expressed transcription factors belonging to
other families. Indeed, using transient expression experi-
ments, we provided evidence that the HOXB7 transacti-
vating potential was increased markedly by NF-kB proteins
[61]. These latter transcription factors play a central role in
the cellular defense against stress, cytokines, and pathogens
[62–64] and regulate a wide spectrum of immune and
inflammatory responses in multiple species [65]. Because it
is believed that transcriptional synergism between distinct
proteins contributes to the regulation of their function,
presumably through protein–protein interactions, it was
expected that HOX proteins and NF-kB could be involved
in such a phenomenon (“cross-talk”).
Surprisingly, HOXB7 transcription potential was in-
creased further by IkB-a, the first identified inhibitor of
NF-kB activity [66, 67]. The N-terminal domain of
HOXB7 and both the ankyrin repeats and the C-terminal
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region of IkB-a were required for the physical interaction.
Hypothetical models that may account for this enhance-
ment of HOXB7 transactivation potential by IkB-a were
proposed [61]. Besides indirect mechanisms, a stabilization
of HOXB7 DNA binding by IkB-a ankyrin repeats may
represent a first pathway. Another mechanism implies the
establishment of HOXB7/NF-kB/IkB-a transcriptional
complexes whose respective transactivation domains con-
tribute to the enhanced effect. Further experimental evi-
dence is needed to investigate whether such hypotheses are
relevant. The answer, however, may come from an addi-
tional mechanism related to the regulation of nuclear
localization of HOX proteins by their interacting partners,
such as IkB-a. IkB-a initially was described as a cytoplas-
mic protein [67]; since then, nuclear localization of IkB-a
has been demonstrated in a variety of cells [68, 69]. Once in
the nucleus, IkB-a can remove NF-kB dimers from func-
tional preinitiation complexes and from their kB DNA
sequences, thus inhibiting NF-kB activity [70]. The way
IkB-a enters into the nucleus has been described recently,
and involves its second ankyrin repeat acting as a newly
described nuclear import sequence [71]. IkB-a nuclear
localization also may imply another additional protein(s)
able to interact with ankyrin repeats [72]. This latter study,
combined with our results, suggests that HOXB7 may be a
candidate. The interaction between HOXB7 and IkB-a
occurred in the absence of DNA, a result that supports this
hypothesis. We also have observed an enhancement of
HOXB7 transcription potential by Bcl3, another member
of the IkB family, which also harbors ankyrin repeats and a
potential NLS (Chariot et al., unpublished results). To date,
it is not known whether IkB-b, whose putative NLS still
has to be identified, can also modulate HOXB7 transcrip-
tion potential. Anyway, it is tempting to speculate that
homeodomain-containing proteins, including HOX gene
products, may represent a family of transcription factors
that are implicated in the regulation of the nuclear local-
ization of other proteins, such as ankyrin repeat-containing
products (Fig. 2). This protein–protein interaction would
allow a mutual regulation of their nuclear localization. In
such a model, further investigation should determine
whether the NLS is provided either by IkB-a or by HOXB7
for the nuclear import pathway and whether the NF-kB
heterodimer interferes with this process.
This potential “cross-talk” between NF-kB/IkB-a pro-
teins and HOXB7 is interesting because of the distinct
physiological processes that require these transcription
factors. Both families of proteins are expressed simulta-
neously in the developing embryo. Indeed, although the
involvement of NF-kB/IkB proteins during development is
unclear, NF-kB gene expression has been detected during
limb morphogenesis, and alteration of the activity of these
proteins causes an arrest of the outgrowth [73, 74]. More-
over, IkB-a is the human homologue of cactus, a protein
that plays a crucial role in the dorso-ventral patterning of
the Drosophila embryo [75]. Since HOX genes clearly are
required to establish the antero-posterior axis of the devel-
oping embryo, it would be interesting to determine whether
mutual regulation between IkB-a and HOX proteins occurs
during the development of both the antero-posterior and
the dorso-ventral axes of the embryo.
Insights into Hox Proteins and Their Interacting Partners:
A Way to Design Pharmacological Treatments?
The critical role played by HOX genes in embryogenesis
has been demonstrated by phenotypic abnormalities caused
by gene disruption as well as by inherited alterations of limb
development due to naturally occurring alterations of HOX
genes [76, 77]. Moreover, the involvement of HOX genes in
hematopoiesis also has been demonstrated based on exten-
sive expression studies and on the leukemogenic effect of
altered HOX genes [78, 79]. On the other hand, the genes
coding for most of the HOX interacting proteins have been
identified through molecular characterization of rearrange-
ments found in leukemia. Taken together, these observa-
tions suggest that a variety of diseases are due to the
disruption of protein–protein interactions involving HOX
proteins, leading to the subsequent dysregulation of the
HOX target genes. Moreover, the genetic programs con-
trolled by the HOX proteins also regulate physiological
functions [80, 81]. A better understanding of these protein
functions and the mechanisms regulating their activity,
including protein–protein interactions, might allow the
development of novel therapies that could specifically
restore and/or affect HOX-dependent regulating pathways.
FIG. 2. Mutual regulation of HOXB7/IkB-a nuclear localiza-
tion through direct protein–protein interaction. A heterodimer
that includes an ankyrin repeat-containing protein (“Ank”) and
a HOX protein (“HOX”) moves to the nucleus and subse-
quently regulates the expression of a HOX target gene. The
ankyrin repeat-containing protein, bound to the NF-kB het-
erodimer in the nucleus, also physically interacts with a HOX
transcriptional complex, which includes HOX proteins and the
co-activator/acetyltransferase complex. These physical interac-
tions contribute to the regulation of the transcriptional ability of
the HOX protein. The basal transcription machinery also is
illustrated.
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CONCLUSIONS
Significant progress has been made recently regarding the
molecular characterization of the transcriptional complexes
involving HOX gene products. The aim of this commentary
was to demonstrate tentatively that elucidation of genetic
programs regulated by HOX genes can be achieved through
identification of HOX interacting partners. Although it is
likely that most of the actors still have to be defined, it is
clear that further investigations regarding the way the
known HOX partners interact with each other will lead to
a better understanding of the crucial role played by HOX
genes in development, differentiation, and disease.
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